Display Settings:

Format

Send to:

Choose Destination
Chem Biol Drug Des. 2009 Sep;74(3):234-45. doi: 10.1111/j.1747-0285.2009.00851.x.

Toward the design of mutation-resistant enzyme inhibitors: further evaluation of the substrate envelope hypothesis.

Author information

  • 1Centro de Química da Madeira, Departamento de Química, Universidade da Madeira, 9000-390 Funchal, Portugal.

Abstract

Previous studies have shown the usefulness of the substrate envelope concept in the analysis and prediction of drug resistance profiles for human immunodeficiency virus protease mutants. This study tests its applicability to several other therapeutic targets: Abl kinase, chitinase, thymidylate synthase, dihydrofolate reductase, and neuraminidase. For the targets where many (> or =6) mutation data are available to compute the average mutation sensitivity of inhibitors, the total volume of an inhibitor molecule that projects outside the substrate envelope V(out), is found to correlate with average mutation sensitivity. Analysis of a locally computed volume suggests that the same correlation would hold for the other targets, if more extensive mutation data sets were available. It is concluded that the substrate envelope concept offers a promising and easily implemented computational tool for the design of drugs that will tend to resist mutations. Software implementing these calculations is provided with the 'Supporting Information'.

PMID:
19703025
[PubMed - indexed for MEDLINE]
PMCID:
PMC2860775
Free PMC Article

Images from this publication.See all images (11)Free text

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Blackwell Publishing Icon for PubMed Central
    Loading ...
    Write to the Help Desk